$CE

Citigroup maintained a 'Buy' rating on Celanese (CE) but lowered its price target from $60.00 to $58.00. GuruFocus values CE at $64.39, suggesting a 30.7% undervaluation. The company has a GF Score of 71/100, with strengths in profitability and valuation but weaknesses in momentum and financial strength.

Celanese (CE) raised prices on four acetyl products, with increases ranging from $0.045 to $0.06 per pound. Q2 net sales for these products were $1.33B, up 28% sequentially, with operating margins at 18%. Success depends on customer acceptance, volume retention, and cost management.

Celanese Corporation (CE) announced price increases for its ultra-high molecular weight polyethylene and polyoxymethylene products in Asia and Europe, effective October 8, 2026. Prices will rise by $0.30/kg in Asia and €0.30/kg in Europe, with no changes in the Americas. The company cited market developments and supply chain disruptions for the increases. Celanese reported 2025 net sales of $9.5 billion.

Celanese (CE) shares rose 7.5% after announcing immediate price hikes for key products in multiple regions, seen as a catalyst for margin recovery. The move is part of broader restructuring efforts, including asset sales. The company maintained its 2026 EPS guidance. The rally is company-specific, not driven by broader market trends. CE operates as a major producer of acetic acid and vinyl acetate monomer.

Celanese (CE) shares fell after the company announced immediate price hikes on key acetyl products in multiple regions. Investors reacted to potential cost pressures and demand concerns, though no changes to price targets were announced. The company's long-term strategy includes cost cuts and debt reduction, but profitability challenges and high debt levels remain risks.

Celanese Corp (CE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Celanese Corporation 222 West Las Colinas Blvd. Suite 900N Irving, Texas 75039 Luis Fernandez-Moreno Elected to Celanese Board of Directors DALLAS (September 16, 2026) - Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announc

Celanese (CE) stock is slipping after a recent rally driven by a bullish analyst call and debt-reduction optimism. Investors are locking in profits, and the company's heavy debt load and recent profitability hit may pressure the stock. Celanese's strong free cash flow supports debt reduction and growth investments, but margin recovery risks remain.

Major indices closed lower Thursday, with the Russell 2000 down 1.04%. Brent Crude surged 7.2% to $108.60 due to U.S.-Iran tensions. Morgan Stanley downgraded Novo Nordisk (NVO) to Underweight, while RBC initiated Dell (DELL) with an Outperform rating and $640 target. Analysts also made calls on Atmos Energy (ATO), Celanese (CE), Check Point (CHKP), Chewy (CHWY), Fortinet (FTNT), Global Payments (GPN), HP (HPQ), and Shopify (SHOP).

KeyBanc initiated coverage on Celanese (NYSE: CE) with an overweight rating and a $57 price target, citing attractive valuation and strong free cash flow yield. The firm estimates the company has sufficient liquidity to repay debt through 2028. Celanese's Q2 2026 earnings beat estimates but revenue missed slightly, with a cautious outlook due to restructuring and leverage concerns.

Celanese (CE) is selling 19% of Nutrinova to Mitsui for $152M, reducing its stake to 11%. The sale, expected to close Q4, will help reduce debt and fund maturities, part of a $1B divestiture goal by 2027. The sold stake generated $4M in 2025 earnings, implying a 38x multiple.